206 related articles for article (PubMed ID: 25142475)
1. Imaging cardiac sarcoidosis by cardiac positron emission tomography (PET): a local experience using a high-fat, low-to-no carbohydrate protocol.
Koh AS; Kok TY; Sim DK; Lath N; Tan RS
Ann Acad Med Singap; 2014 Jul; 43(7):383-5. PubMed ID: 25142475
[No Abstract] [Full Text] [Related]
2. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
Christopoulos G; Jouni H; Acharya GA; Blauwet LA; Kapa S; Bois J; Chareonthaitawee P; Rodriguez-Porcel MG
J Nucl Cardiol; 2021 Apr; 28(2):661-671. PubMed ID: 31111450
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
Lu Y; Grant C; Xie K; Sweiss NJ
Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
[TBL] [Abstract][Full Text] [Related]
4. The Multi-modality Cardiac Imaging Approach to Cardiac Sarcoidosis.
Ricci F; Mantini C; Grigoratos C; Bianco F; Bucciarelli V; Tana C; Mastrodicasa D; Caulo M; Donato Aquaro G; Raffaele Cotroneo A; Gallina S
Curr Med Imaging Rev; 2019; 15(1):10-20. PubMed ID: 31964322
[TBL] [Abstract][Full Text] [Related]
5. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
[TBL] [Abstract][Full Text] [Related]
6. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
Paz YE; Bokhari S
Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
[TBL] [Abstract][Full Text] [Related]
7. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
Skali H; Schulman AR; Dorbala S
Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis.
Skali H; Schulman AR; Dorbala S
Curr Cardiol Rep; 2013 Apr; 15(4):352. PubMed ID: 23544184
[TBL] [Abstract][Full Text] [Related]
9. Patient page-sarcoidosis imaging.
Bois JP; Chareonthaitawee P
J Nucl Cardiol; 2019 Feb; 26(1):222-226. PubMed ID: 29094295
[TBL] [Abstract][Full Text] [Related]
10. Right ventricular mass: a rare presentation of cardiac sarcoidosis.
Bertic M; Tandon S; Wisenberg G
Eur Heart J; 2016 Mar; 37(11):859. PubMed ID: 26705387
[No Abstract] [Full Text] [Related]
11. Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
Kherajani P; Farag AA; Morgan WS; Hage FG; Bhambhvani P
J Nucl Cardiol; 2023 Dec; 30(6):2525-2530. PubMed ID: 37524998
[TBL] [Abstract][Full Text] [Related]
12. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis.
Soussan M; Brillet PY; Nunes H; Pop G; Ouvrier MJ; Naggara N; Valeyre D; Weinmann P
J Nucl Cardiol; 2013 Feb; 20(1):120-7. PubMed ID: 23188627
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.
Ishida Y; Yoshinaga K; Miyagawa M; Moroi M; Kondoh C; Kiso K; Kumita S
Ann Nucl Med; 2014 May; 28(4):393-403. PubMed ID: 24464391
[No Abstract] [Full Text] [Related]
15. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
[TBL] [Abstract][Full Text] [Related]
16. The role of positron emission tomography in the assessment of cardiac sarcoidosis.
Genovesi D; Bauckneht M; Altini C; Popescu CE; Ferro P; Monaco L; Borra A; Ferrari C; Caobelli F
Br J Radiol; 2019 Aug; 92(1100):20190247. PubMed ID: 31166768
[TBL] [Abstract][Full Text] [Related]
17. Cardiac FDG/PET imaging mimicking sarcoidosis.
Lai JKC; Teo E; Lichtenstein M; Toh HB; Sivaratnam D
J Nucl Cardiol; 2019 Jun; 26(3):1025-1027. PubMed ID: 30627883
[No Abstract] [Full Text] [Related]
18. Detection of cardiac sarcoidosis by macrophage-directed somatostatin receptor 2-based positron emission tomography/computed tomography.
Reiter T; Werner RA; Bauer WR; Lapa C
Eur Heart J; 2015 Sep; 36(35):2404. PubMed ID: 26093640
[No Abstract] [Full Text] [Related]
19. [Cardiac sarcoidosis detected by FDG-PET].
Goto K; Okamoto E; Morita M; Sasamoto T; Endo M; Umezawa K; Suguta M; Kaneko Y; Nakano A; Arai M; Hasegawa A; Kurabayashi M
Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1396-8. PubMed ID: 16097596
[No Abstract] [Full Text] [Related]
20. Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.
Brancato SC; Arrighi JA
J Nucl Cardiol; 2011 Apr; 18(2):371-4. PubMed ID: 21318450
[No Abstract] [Full Text] [Related]
[Next] [New Search]
